Improving seizure prediction using wearable sensors and scalp EEG.
Optimizing Pharmacotherapy with Noninvasive Wearable Sensors and Subscalp EEG
This study is testing a new way to help people with epilepsy predict when a seizure might happen by using safe, wearable sensors on their wrist and head, so they can take action to stay safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10561595 on NIH RePORTER |
What this research studies
This research focuses on enhancing the ability to predict seizures in patients with epilepsy by utilizing noninvasive wearable sensors and subscalp EEG technology. By monitoring physiological signals from both the scalp and wrist, the study aims to identify patterns that could indicate an impending seizure. This approach seeks to empower patients by allowing them to take preventive measures, such as adjusting their activities or using fast-acting medications. The research is particularly significant as it aims to develop a reliable method for seizure forecasting without the risks associated with invasive procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with epilepsy who experience unpredictable seizures.
Not a fit: Patients who do not have epilepsy or those whose seizures are well-controlled and predictable may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for patients with epilepsy by providing them with the tools to anticipate and manage seizures more effectively.
How similar studies have performed: Previous studies have shown promise in seizure prediction using similar noninvasive techniques, indicating a potential for success in this novel approach.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Brinkmann, Benjamin H — Mayo Clinic Rochester
- Study coordinator: Brinkmann, Benjamin H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.